Awards & Advancement

IntelGenx creates scientific advisory board

Friday, February 5, 2016

IntelGenx has created a scientific advisory board with the engagement of Dr. Ludwig Aigner and Dr. Barry Greenberg. Dr. Horst G. Zerbe will act as the chairman and Nadine Paiement (vice president, R&D) will serve as vice-chair of the scientific advisory board. 

[Read More]

Laura Donohue joins BRANY’s IRB team

Tuesday, February 2, 2016

Laura Donohue has joined Biomedical Research Alliance of New York (BRANY), a national organization providing support services to sponsors and investigators involved in research, as IRB supervisor. She will work with BRANY’s central, AAHRPP-accredited IRB.

[Read More]

CRF Health appoints Claudine Paccio SVP

Tuesday, January 26, 2016

CRF Health, a global provider of eCOA solutions for the life sciences industry, announces the appointment of Claudine Paccio as the company’s senior vice president, Delivery Services. Paccio will head-up client delivery and development activities at CRF Health, where she will provide leadership, structure and processes to enhance the delivery of the company’s services and solutions to its rapidly growing customer base.

[Read More]

Virginia Bio expands board of directors

Tuesday, January 26, 2016

Virginia Bio, a statewide nonprofit association representing life science industry in the Commonwealth of Virginia, elected five new members to their board of directors for a term of three years. The election took place in December at the Virginia Bio Annual Membership in Richmond, Virginia.

[Read More]

Miami Cancer Institute names Mehta deputy director, radiology chief

Tuesday, January 26, 2016

Minesh Mehta, M.D., an expert in radiation oncology, proton therapy and cancer research, has joined the executive leadership of Miami Cancer Institute at Baptist Health South Florida as deputy director and chief of radiation oncology. Dr. Mehta will position Miami Cancer Institute’s proton therapy center—the only one of its kind in South Florida and one of fewer than two dozen of its kind in the U.S.—as the region’s top destination for this leading-edge treatment.

[Read More]

Stundick joins Spero Therapeutics

Friday, January 22, 2016

Spero Therapeutics, a biopharmaceutical company founded to develop novel therapies for the treatment of bacterial infections, has announced the appointment of Melissa Stundick, Ph.D., to the newly created leadership position of head of Strategic Alliances.

[Read More]